Prognostic implications of ischemic mitral regurgitation following non-ST-Segment elevation acute myocardial infarction
Introduction: Ischemic mitral regurgitation (MR) is a common complication of acute myocardial infarction and has a negative impact on prognosis. However, few studies have been carried out on MR after non-ST-segment elevation acute myocardial infarction (NSTEMI).
Aim: Investigate the clinical predictors of ischemic MR and its impact on the outcome after 1st NSTEMI .
Methods: 40 consecutive patients were selected retrospectively after a first NSTEMI. Each underwent echocardiography and coronary angiography during their hospital admission. Patients were divided into two groups according to the presence or absence of MR at echocardiography: Group I : 20 patients without MR , Group II : 20 patients with MR. The patients were followed up clinically for at least one year. The incidence of readmission for heart failure, unstable angina, reinfarction, or all combined (i.e, major adverse cardiac event [MACE]) was recorded.
Results: The patients’ mean age was 59.62 ± 10.97 years and 67.5 % were male. They were followed–up for a median of 640.5 days . No significant differences between both groups regarding baseline data ,cardiac isoenzymes , or revascularization (P > 0.05) , but there was significantly increased number of diseased coronary arteries in MR group (P 0.04). LA diameter was significantly increased with decreased LVEF% and increased wall motion abnormalities in MR group ((P < 0.05) . During follow-up period ,more admissions for unstable angina were seen in patients with MR but with little significance (P 0.05) . Regarding MACE, a greater incidence was found in the MR group (P<.05). Using Kaplan-Meier curves ,a long-term association of MACE with the presence of MR was found (P 0.04), and a higher grades of MR were associated with poor prognosis (P .05) .
In conclusion: Ischemic MR yield poor prognosis. Thus, current MR should be carefully assessed after an NSTEMI,and probably requires even more meticulous treatment including early revascularization and stricter follow-up than usual .
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access and Benefits of Publishing Open Access).